Modeling Human Pacemaker Maturation with SAN-Plexus Assembloids

Study Background and Research Question

The sinoatrial node (SAN) functions as the heart's primary pacemaker, orchestrating cardiac rhythm by generating spontaneous electrical impulses. These impulses are dynamically regulated by intrinsic cardiac neural networks, particularly the cardiac ganglionated plexus. Human SAN research has been historically limited by tissue scarcity, complex 3D anatomy, and interspecies differences that undermine the translational value of animal models. While human pluripotent stem cell (hPSC) differentiation methods can generate SAN-like pacemaker cells, they often lack the architectural and neurogenic complexity necessary to recapitulate the full spectrum of SAN maturation and neural modulation. The central research question addressed by this study is how to reproducibly model neuron-to-pacemaker interactions and maturation in a human-relevant, in vitro system.

Key Innovation from the Reference Study

According to the reference study, the investigators developed a tri-assembloid system by integrating human PSC-derived SAN organoids (SANOs), cardiac ganglionated plexus organoids (CGPOs), and atrial-like cardiac organoids. This human assembloid model recapitulates the 3D architecture, cellular heterogeneity, and functional innervation of the native SAN. By doing so, the platform enables precise interrogation of how intrinsic cardiac neurons modulate SAN automaticity, pacemaker-to-atrial conduction, and associated functional maturation, including disease phenotypes.

Methods and Experimental Design Insights

The study employed a stepwise approach to generate and assemble organoid components from hPSCs. SANOs were derived using cardiac differentiation protocols that promote TBX18+ and ISL1+ progenitor lineages, yielding pacemaker cells characterized by core transcriptional regulators, including SHOX2, ISL1, and TBX3, and ion channels such as HCN4. CGPOs were differentiated to recapitulate cardiac intrinsic neurons, while atrial-like organoids provided a downstream target for pacemaker-driven conduction. The assembloid assembly involved spatially integrating these three components, resulting in a system capable of modeling pacemaker origin, conduction, and neural modulation.

Electrophysiological characterization included patch-clamp and multi-electrode array recordings to quantify spontaneous firing, conduction velocity, and response to neural stimulation. Molecular profiling utilized single-cell and spatial transcriptomics to resolve cell-type-specific gene expression patterns and map neuron-pacemaker communication axes. Functional manipulation, including pharmacological and genetic perturbation of neuro-cardiac signaling pathways, allowed the team to dissect the contribution of candidate molecules such as the prosaposin-GPR37 signaling axis.

Core Findings and Why They Matter

The tri-assembloid platform displayed robust SAN phenotypes, including spontaneous diastolic depolarization, slow upstroke action potentials, and effective pacemaker-to-atrial conduction, closely mirroring in vivo human SAN properties. Integration of CGPOs conferred functional innervation, enabling real-time modulation of pacemaker activity by intrinsic cardiac neurons. Notably, spatial transcriptomic analyses revealed a neuron-to-pacemaker signaling program in which CGPO-derived prosaposin activated the SAN-enriched GPR37 receptor to promote maturation and functional specialization of pacemaker cells. This neuron-guided maturation was essential for establishing conduction fidelity and resilience to disease-associated dysfunctions (reference study).

Importantly, the system permitted mechanistic dissection of beta-adrenergic receptor signaling and GPCR pathways that underlie SAN automaticity and neural responsiveness—key elements in cardiovascular research and the study of conduction disorders.

Comparison with Existing Internal Articles

Internal resources such as "Modeling Human Pacemaker Maturation with SAN-Plexus Assembloids" and "Modeling Human SAN-Plexus Interactions with PSC-Derived Assembloids" provide complementary perspectives on the use of PSC-derived organoids to interrogate SAN-neural interactions. These studies similarly emphasize the value of multi-component human in vitro models for dissecting neuron-to-pacemaker signaling and highlight the translational potential for understanding conduction disorders. The present reference paper extends these findings by integrating spatial transcriptomics and directly linking neural input to molecular maturation pathways—an advancement not fully realized in earlier models.

Additionally, the article "Isoproterenol Sulfate Dihydrate: Benchmarks for Beta-Adrenergic Research" underscores the relevance of pharmacological tools such as isoproterenol hemisulfate for probing beta-adrenergic and GPCR signaling in pacemaker systems, an approach that is well-aligned with the neural modulation strategies examined in the reference study.

Limitations and Transferability

While the tri-assembloid system achieves unprecedented fidelity in modeling human SAN-neural interactions, certain limitations must be acknowledged. The maturation state of PSC-derived organoids, though advanced by neuron-driven cues, may not fully replicate the in vivo developmental timeline or environmental complexity of native cardiac tissue. Autonomic modulation in vivo involves additional inputs (e.g., sympathetic regulation) not directly modeled in this system. Furthermore, the platform's scalability for high-throughput screening or integration with patient-derived iPSC lines for personalized medicine remains to be fully validated.

Nevertheless, the platform offers a valuable bridge between reductionist cell culture systems and the complexity of human cardiac physiology, supporting the study of congenital SAN dysfunction, conduction disorders, and neuro-cardiac crosstalk with direct translational relevance.

Protocol Parameters

• SAN organoid induction: Initiate cardiac differentiation from hPSCs using protocols optimized for TBX18+/ISL1+ lineage specification; monitor expression of SHOX2, ISL1, TBX3, and HCN4 to confirm pacemaker identity.
• Cardiac ganglionated plexus organoid differentiation: Employ neural crest lineage protocols and validate by neural marker expression prior to integration.
• Assembloid assembly: Spatially combine SAN organoids, CGPOs, and atrial-like organoids following pre-culture to establish inter-organoid communication; allow for maturation over 7–14 days before functional assays.
• Electrophysiological assessment: Use patch-clamp and multi-electrode array recordings to evaluate spontaneous pacemaker activity and conduction properties in assembloids.
• Beta-adrenergic stimulation (workflow suggestion): For studies of GPCR signaling and cAMP/PKA pathway activation, apply isoproterenol hemisulfate to the assembloid culture and monitor changes in pacing and conduction.

Research Support Resources

To facilitate mechanistic studies of beta-adrenergic and GPCR signaling in pacemaker systems, researchers can incorporate Isoproterenol sulfate dihydrate (SKU C6402) into SAN-plexus assembloid workflows. This compound is a well-characterized, non-selective beta-adrenergic agonist with reliable solubility and high purity, making it suitable for studies of beta-adrenergic receptor modulation, cAMP/PKA pathway activation, and neuro-cardiac signaling. For optimal results, follow storage and handling guidelines as detailed in the product information. Use of standardized reagents such as those from APExBIO supports reproducibility and data integrity in cardiovascular research.